Market Place
Sourcing Support
Delcath Announces FDA IND Clearance for HEPZATO™ in Colorectal Cancer
02 Dec 2024 //
BUSINESSWIRE
Delcath Systems Reports Q3 2024 Results & Business Highlights
08 Nov 2024 //
BUSINESSWIRE
Delcath Systems to Participate in Upcoming Investor Conferences
01 Nov 2024 //
BUSINESSWIRE
Delcath Systems to Host Third Quarter 2024 Earnings Call
25 Oct 2024 //
BUSINESSWIRE
Delcath Systems Announces Preliminary Q3 2024 Revenue Results
17 Oct 2024 //
BUSINESSWIRE
Delcath Reports Inducement Grants Under Nasdaq Rule
20 Sep 2024 //
BUSINESSWIRE
Delcath Presents HEPZATO KIT Data At ESMO 2024
16 Sep 2024 //
BUSINESSWIRE
Delcath Systems To Participate In H.C. Wainwright Conference
28 Aug 2024 //
BUSINESSWIRE
Delcath Systems Announces Positive Study Results For Liver Therapy
28 Aug 2024 //
BUSINESSWIRE
Delcath Systems Announces Positive Outcomes From Hepatic Perfusion Study
27 Aug 2024 //
BUSINESSWIRE
Delcath Reports Promising Results On Hepatic Chemosaturation For Liver Tumors
26 Aug 2024 //
BUSINESSWIRE
Delcath Systems Announces Poster Presentation at the 2024 ESMO Congress
20 Aug 2024 //
BUSINESSWIRE
Delcath Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
12 Aug 2024 //
BUSINESSWIRE
Delcath Systems Reports Second Quarter 2024 Results and Business Highlights
05 Aug 2024 //
BUSINESSWIRE
Delcath Systems to Host Second Quarter 2024 Earnings Call
22 Jul 2024 //
BUSINESSWIRE
Delcath: Bridget Martell Appointed To Board Of Directors
28 May 2024 //
BUSINESSWIRE
Delcath Systems Reports First Quarter 2024 Results and Business Highlights
14 May 2024 //
PR NEWSWIRE
Delcath Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
04 Apr 2024 //
PR NEWSWIRE
Delcath Systems Announces a Comparative Study of Chemosat
16 Oct 2023 //
PR NEWSWIRE
Delcath`s cancer treatment Hepzato Kit finally scores FDA nod
15 Aug 2023 //
FIERCE PHARMA
Delcath Systems Announces Private Placement of $6.2 Million
08 Dec 2022 //
PRNEWSWIRE
Delcath Systems to Present at Upcoming Investor Conferences in August
27 Jul 2022 //
PRNEWSWIRE
Delcath Systems Announces Private Placement of $5.0 Million
18 Jul 2022 //
PRNEWSWIRE
Delcath Systems Reports First Quarter 2022 Results and Provides Business Update
10 May 2022 //
GLOBENEWSWIRE
Delcath Announces Poster Presentation at the 2022 ASCO Annual Meeting
09 May 2022 //
GLOBENEWSWIRE
Delcath Systems to Host First Quarter 2022 Results
28 Apr 2022 //
GLOBENEWSWIRE
Delcath to Participate in Canaccord Genuity Horizons in Oncology Conference
08 Apr 2022 //
GLOBENEWSWIRE
Delcath Systems to Participate in the Lytham Partners Spring 2022
29 Mar 2022 //
GLOBENEWSWIRE
Delcath Systems Reports Fourth Quarter and Full-Year 2021 Results
25 Mar 2022 //
GLOBENEWSWIRE
Delcath Systems to Host Q4 and FY 2021 Results
15 Mar 2022 //
GLOBENEWSWIRE
Delcath Systems to Present at the 34th Annual Roth Conference
10 Mar 2022 //
GLOBENEWSWIRE
Delcath Systems Achieves Medical Device Regulation Certification for CHEMOSAT
02 Mar 2022 //
GLOBENEWSWIRE
Delcath Systems Announces Move to a Direct Sales & Marketing Model for CHEMOSAT®
22 Feb 2022 //
GLOBENEWSWIRE
Results of Single Center Study on Delcath’s CHEMOSAT Hepatic Delivery System
03 Feb 2022 //
GLOBENEWSWIRE
Delcath Systems to Hold Investor Update on December 2, 2021
05 Nov 2021 //
GLOBENEWSWIRE
Delcath Systems Announces Second Quarter 2021 Results
10 Aug 2021 //
GLOBENEWSWIRE
Delcath Systems Announces Second Quarter 2021 Results
10 Aug 2021 //
GLOBENEWSWIRE
Delcath Systems to Present at Upcoming Virtual Investor Conferences
05 Aug 2021 //
GLOBENEWSWIRE
Delcath to Present at Access to Giving Virtual Conference on July 13, 2021
07 Jul 2021 //
GLOBENEWSWIRE
Positive Preliminary Results from Delcath Systems’ FOCUS Trial Presented at ASCO
07 Jun 2021 //
GLOBENEWSWIRE
Delcath Systems Announces Oral Presentation at the American Society
30 Apr 2021 //
GLOBENEWSWIRE
